These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25832744)
21. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells. Zheng Y; He L; Wan Y; Song J Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822 [TBL] [Abstract][Full Text] [Related]
22. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Guney I; Wu S; Sedivy JM Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3645-50. PubMed ID: 16537449 [TBL] [Abstract][Full Text] [Related]
24. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Pardal R; Molofsky AV; He S; Morrison SJ Cold Spring Harb Symp Quant Biol; 2005; 70():177-85. PubMed ID: 16869752 [TBL] [Abstract][Full Text] [Related]
25. Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice. Sato S; Kawamata Y; Takahashi A; Imai Y; Hanyu A; Okuma A; Takasugi M; Yamakoshi K; Sorimachi H; Kanda H; Ishikawa Y; Sone S; Nishioka Y; Ohtani N; Hara E Nat Commun; 2015 Apr; 6():7035. PubMed ID: 25923845 [TBL] [Abstract][Full Text] [Related]
26. Bmi1 Overexpression in Mesenchymal Stem Cells Exerts Antiaging and Antiosteoporosis Effects by Inactivating p16/p19 Signaling and Inhibiting Oxidative Stress. Chen G; Zhang Y; Yu S; Sun W; Miao D Stem Cells; 2019 Sep; 37(9):1200-1211. PubMed ID: 30895687 [TBL] [Abstract][Full Text] [Related]
27. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Vonlanthen S; Heighway J; Altermatt HJ; Gugger M; Kappeler A; Borner MM; van Lohuizen M; Betticher DC Br J Cancer; 2001 May; 84(10):1372-6. PubMed ID: 11355949 [TBL] [Abstract][Full Text] [Related]
28. PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a. Zeng N; Yang KT; Bayan JA; He L; Aggarwal R; Stiles JW; Hou X; Medina V; Abad D; Palian BM; Al-Abdullah I; Kandeel F; Johnson DL; Stiles BL Aging Cell; 2013 Dec; 12(6):1000-11. PubMed ID: 23826727 [TBL] [Abstract][Full Text] [Related]
29. The molecular balancing act of p16(INK4a) in cancer and aging. LaPak KM; Burd CE Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988 [TBL] [Abstract][Full Text] [Related]
30. Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701 [TBL] [Abstract][Full Text] [Related]
31. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Miyazaki M; Miyazaki K; Itoi M; Katoh Y; Guo Y; Kanno R; Katoh-Fukui Y; Honda H; Amagai T; van Lohuizen M; Kawamoto H; Kanno M Immunity; 2008 Feb; 28(2):231-45. PubMed ID: 18275833 [TBL] [Abstract][Full Text] [Related]
32. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of p16 Khatiwala RV; Zhang S; Li X; Devejian N; Bennett E; Cai C Stem Cell Rev Rep; 2018 Aug; 14(4):612-625. PubMed ID: 29675777 [TBL] [Abstract][Full Text] [Related]
34. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008 [TBL] [Abstract][Full Text] [Related]
35. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753 [TBL] [Abstract][Full Text] [Related]
36. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation. Lee MO; Lee HJ; Kim MA; Kim EK; Lee JH; Heo JH; Lee SH; Cho SH; Fornace AJ; Jeong HC; Cha HJ J Thorac Oncol; 2011 Mar; 6(3):423-31. PubMed ID: 21164364 [TBL] [Abstract][Full Text] [Related]
38. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Burd CE; Sorrentino JA; Clark KS; Darr DB; Krishnamurthy J; Deal AM; Bardeesy N; Castrillon DH; Beach DH; Sharpless NE Cell; 2013 Jan; 152(1-2):340-51. PubMed ID: 23332765 [TBL] [Abstract][Full Text] [Related]
39. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368 [TBL] [Abstract][Full Text] [Related]